Sort by:
83 products
83 products
Mevicfor 500 mg
Comparable to: Glucophage
Active ingredient: Metformin
Concentration: 500 mg per tablet
Presentation: Box with 100 tablets
Laboratory: Victory Enterprises
Origin: Mexico
This generic medication is used for the treatment of type 2 diabetes mellitus, helping to control blood glucose levels and improve insulin sensitivity.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
MEVICFOR (Metformin) 850 MG 50 TAB
Comparable to: Glucophage
Active ingredient: METFORMIN
Strength: 850 MG
Presentation: 50 TAB
Laboratory: ALPHARMA
Origin: Made in Mexico
Metformin is a fundamental medication for the treatment of type 2 diabetes. It works by reducing glucose production in the liver and improving the body's sensitivity to insulin, which helps lower blood sugar levels. It is effective for glycemic control and the prevention of long-term complications.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before taking any medication.
MINODIAB (GLIPIZIDE) 10 MG 30 TABLETS
Comparable to: GLUCOTROL
Active ingredient: GLIPIZIDE
Concentration: 10 MG
Presentation: 30 TABLETS
Laboratory: PFIZER
Origin: Made in Mexico
Glipizide is an oral medication for type 2 diabetes, belonging to the sulfonylurea class. It works by stimulating the beta cells of the pancreas to release insulin, which helps reduce blood glucose levels. It is useful for maintaining adequate glycemic control.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
OCRIX (GLIBENCLAMIDE) 5MG 50T
Comparable to: Ocrix
Active ingredient: GLIBENCLAMIDE
Concentration: 5MG
Presentation: 50T
Laboratory: BIOMEP
Origin: Made in Mexico
Glibenclamide is an oral hypoglycemic agent used for type 2 diabetes. It stimulates the pancreas to produce and release more insulin, thereby helping to reduce high blood glucose levels. It contributes to effective sugar control and improved disease management.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
ONGLYZA
Comparable to: N/A
Active substance: SAXAGLIPTIN
Concentration: 5MG
Presentation: 28TAB
Laboratory: ASTRAZENECA
Origin: Made in Mexico
Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It improves glycemic control by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. It helps reduce blood sugar levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
Comparable to: Wegovy
Active ingredient: Semaglutide
Concentration: 0.25 Mg
Presentation: Solution for Injection, 1 Pre-filled Pen of 1.5 mL
Laboratory: NOVO NORDISK
Origin: Made in Mexico
Ozempic 0.25 mg is an injectable solution with semaglutide, a GLP-1 receptor agonist, used for the control of type 2 diabetes. It helps reduce blood sugar levels, improve insulin secretion, and promote weight loss. It is administered once a week, facilitating disease management.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PREDIAL 500MG 150ML SOLUTION (METFORMIN)
Comparable to: Glucophage
Active ingredient: METFORMIN
Concentration: 500MG
Presentation: 150ML SOLUTION
Laboratory: SILANES
Origin: Made in Mexico
Metformin is a fundamental medication for the treatment of type 2 diabetes. It works by reducing glucose production in the liver and improving the body's sensitivity to insulin, which helps to lower blood sugar levels. It is effective for glycemic control and the prevention of long-term complications.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Robergen (Metformin) 500 mg
Comparable to: N/A
Active ingredient: Metformin
Concentration: 500 mg per tablet
Presentation: Box with 100 tablets
Laboratory: GENETICA
Origin: Made in Mexico
This brand-name medication is an oral antidiabetic drug used for the treatment of type 2 diabetes mellitus. It primarily acts by reducing glucose production in the liver and improving the body's cells' sensitivity to insulin. It helps control blood sugar levels and may promote weight loss in some patients.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
RYBELSUS (SEMAGLUTIDE) 14 MG 30 TABLETS
Comparable to: Ozempic
Active ingredient: Semaglutide
Concentration: 14 MG
Presentation: 30 TABLETS
Laboratory: NOVO NORDISK
Origin: Made in Mexico
Semaglutide is a GLP-1 receptor agonist, used for the treatment of type 2 diabetes and chronic weight management. It helps regulate blood sugar levels, decreases appetite, and promotes a feeling of satiety, which contributes to weight loss.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.
RYBELSUS 7 mg
Sustancia activa: Semaglutida
Concentración: 7 mg por tableta
Presentación: Caja con 30 tabletas
Laboratorio: Novo Nordisk
Origen: México
RYBELSUS es un medicamento antidiabético oral utilizado para el control de la glucosa en sangre en adultos con diabetes tipo 2. Contiene semaglutida, un análogo del GLP-1 que estimula la secreción de insulina dependiente de glucosa, reduce la secreción de glucagón y disminuye el apetito, contribuyendo al control glucémico y al manejo del peso corporal.
El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.
SITAGLIPTINA 100 mg
Marca: Amsa | Presentación: 14 comprimidos | Concentración: 100 mg
Sitagliptina 100 mg Amsa es un medicamento hipoglucemiante oral perteneciente a la clase de los inhibidores de la DPP-4 (dipeptidil peptidasa-4), indicado para el control de la glucosa en sangre en adultos con diabetes mellitus tipo 2. Ayuda al páncreas a producir más insulina cuando los niveles de azúcar en sangre son elevados y reduce la cantidad de glucosa producida por el hígado.
Información del medicamento
- Principio activo: Sitagliptina
- Concentración: 100 mg por comprimido
- Forma farmacéutica: Comprimidos recubiertos
- Presentación: Caja con 14 comprimidos
- Laboratorio: Amsa
- Clase terapéutica: Inhibidor de DPP-4 / Antidiabético oral
Indicaciones
- Tratamiento de la diabetes mellitus tipo 2 en adultos
- En combinación con dieta y ejercicio para mejorar el control glucémico
- Puede usarse en monoterapia o combinado con otros antidiabéticos (metformina, sulfonilureas, insulina), según indicación médica
Modo de administración
- Vía oral
- Dosis habitual: 1 comprimido de 100 mg una vez al día
- Puede tomarse con o sin alimentos
- Seguir estrictamente las indicaciones del médico tratante
Advertencias
- Venta bajo receta médica
- No automedicarse ni modificar la dosis sin supervisión médica
- Mantener fuera del alcance de los niños
- Conservar en lugar seco, fresco y alejado de la luz directa
- Leer cuidadosamente el instructivo y prospecto incluidos en la caja
Este medicamento requiere prescripción médica. Consulte a su médico o farmacéutico antes de iniciar, modificar o suspender el tratamiento.
SITAGLIPTIN (JANUVIA) 100MG Camber WITH 28 TABLETS
Comparable to: Januvia
Active ingredient: SITAGLIPTIN
Concentration: 100MG
Presentation: 28 TABLETS
Laboratory: CAMBER
Origin: Made in Mexico
Sitagliptin is a DPP-4 inhibitor used for type 2 diabetes. It works by increasing active incretin levels in the body, which improves the pancreas's ability to release insulin and reduce glucagon when sugar levels are high. It contributes to effective glycemic control.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before taking any medication.
SITAGLIPTIN (JANUVIA) CAMBER 50MG C/28 TABLETS
Comparable to: Januvia
Active substance: SITAGLIPTIN
Concentration: 50MG
Presentation: 28 TABLETS
Laboratory: CAMBER
Origin: Made in Mexico
Sitagliptin is a DPP-4 inhibitor used for type 2 diabetes. It works by increasing active incretin levels in the body, which improves the pancreas's ability to release insulin and reduce glucagon when sugar levels are high. It contributes to effective glycemic control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SITAGLIPTIN/METFORMIN (Camber) 50MG/850MG C/56 TABLETS
Comparable to: Janumet
Active ingredient: SITAGLIPTIN / METFORMIN
Concentration: 50MG/850MG
Presentation: 56 TABLETS
Manufacturer: CAMBER
Origin: Made in Mexico
This combined therapy of Sitagliptin and Metformin is for patients with type 2 diabetes. Sitagliptin enhances insulin release, and Metformin decreases glucose production in the liver, in addition to improving insulin sensitivity. It offers comprehensive and effective blood sugar control.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>